India to Malaysia: Piperacillin Export Trade Route
India has recorded 60 verified shipments of Piperacillin exported to Malaysia, representing a combined trade value of $6.2M USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $103.1K USD. The leading Indian exporter is EUGIA PHARMA SPECIALITIES LIMITED, which accounts for 36% of total export value with 23 shipments worth $2.2M USD. On the buying side, HONG LEONG BANK BERHAD is the largest importer in Malaysia with $2.6M USD in purchases. The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA LTD — together control 82% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Malaysia Piperacillin corridor is one of India's established pharmaceutical export routes, with 60 shipments documented worth a combined $6.2M USD. The route is dominated by EUGIA PHARMA SPECIALITIES LIMITED, which alone accounts for roughly 36% of all export value, reflecting the consolidated nature of India's piperacillin manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $103.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with piperacillin's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 10.6%, placing it at rank #10 among India's top piperacillin export destinations globally.
On the import side, key buyers of Indian piperacillin in Malaysia include HONG LEONG BANK BERHAD, HONG LEONG BANK BERHAD,, Hong Leong Bank Berhad and 8 others. HONG LEONG BANK BERHAD is the single largest importer with 26 shipments valued at $2.6M USD.
Route Characteristics
- Average transit
